We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

ERBA MANNHEIM

Erba Mannheim is an IVD solutions provider focused on improving health outcomes in developing nations. Originally fou... read more Featured Products: More products

Download Mobile App





Erba Mannheim Showcases Exciting New Introductions at MEDLAB Middle East 2021

By LabMedica International staff writers
Posted on 22 Jun 2021
Erba Mannheim (London, UK) showcased some of its exciting new introductions at MEDLAB Middle East 2021, the MENA region’s largest medical laboratory exhibition and congress, which took place at the Dubai World Trade Centre from 21-24 June.

Erba introduced the fully automated ELAN 30s, a complete solution for lab ELISA workflow that allows users to develop new, flexible analytical workflows by taking advantage of smart scheduling software. More...
By combining up to six different assays in a single run users can break the traditional two or four plate mold and create ‘clinical panel’ based workflows. Multiple reporting formats enhance the final steps of the process and allow the user to report faster with more convenience.

Erba also exhibited its new hematology analyzers - the H360 automated 3 part differential analyzer and H560 automated 5 part differential hematology analyzer, alongside the Elite 580 automated 5-part hematology analyzer with continuous loading capacity. Also on display at this year’s MEDLAB Middle East 2021 edition was the LAURA XL fully automated urine analyzer that combines urine strip reading with digital microscopy. The two-module integrated station consists of one module which performs analysis of the chemical parameters of urine on diagnostic test strips using reflective photometry; and one module performs urinary sediment examination using automated microscopy technology in a format compatible with manual microscopy. In addition, Erba showcased the next generation electrolyte analyzer, EC 90 ISE, which employs cutting edge technology to take laboratory electrolyte measurements to new heights. The EC 90 electrolyte analyzer features next generation thick film, maintenance-free electrodes in all-in-one sensor cartridge.

Alongside these new products, the company presented the ErbaMDx SARS-COV-2 RT-PCR kit, a molecular diagnostic test that aids the detection and diagnosis of COVID-19 infections and is based on latest nucleic acid amplification technologies. It is a real-time reverse transcriptase PCR test that has been developed utilizing universally trusted priming sites with updated primer sequences to maximize long term performance.

Related Links:
Erba Mannheim


Gold Member
Blood Gas Analyzer
Stat Profile pHOx
POC Helicobacter Pylori Test Kit
Hepy Urease Test
Gold Member
Hematology Analyzer
Medonic M32B
Pipette
Accumax Smart Series
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Hematology

view channel
Image: Residual leukemia cells may predict long-term survival in acute myeloid leukemia (Photo courtesy of Shutterstock)

MRD Tests Could Predict Survival in Leukemia Patients

Acute myeloid leukemia is an aggressive blood cancer that disrupts normal blood cell production and often relapses even after intensive treatment. Clinicians currently lack early, reliable markers to predict... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.